Demis Hassabis and John M. Jumper were part of a Google DeepMind team whose A.I. technology predicts protein shapes. David Baker designed “a new protein that was unlike any other,” the committee said.

The Nobel Prize in Chemistry was awarded on Wednesday to David Baker at the University of Washington “for computational protein design” and to Demis Hassabis and John M. Jumper of Google DeepMind “for protein structure prediction.”

This year’s prize is about the “chemical tools for life,” the Nobel Committee for Chemistry said in announcing the prize. “Work that once took years now takes just a few minutes thanks to this year’s chemistry laureates.”

Dr. Hassabis and Dr. Jumper, the committee said, have used their A.I. model AlphaFold2 to calculate the structure of all human proteins. The researchers “also predicted the structure of virtually all the 200 million proteins that researchers have so far discovered when mapping Earth’s organisms,” the committee said.

Dr. Hassabis and Dr. Jumper were part of a team at Google DeepMind, the company’s central A.I. lab, that developed a technology called AlphaFold. This A.I. technology can rapidly and reliably predict the physical shape of proteins and enzymes — the microscopic mechanisms that drive the behavior of viruses, bacteria, the human body and all other living things.

Biochemists have used the technology to speed the discovery of medicines, and it could also lead to new biological tools such as enzymes that efficiently break down plastic bottles and convert them into materials that are easily reused and recycled.

Proteins begin as strings of chemical compounds, before twisting and folding into three-dimensional shapes that define what they can and cannot do. Before the arrival of AlphaFold, scientists would spend months or even decades trying to pinpoint the precise shape of individual proteins.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.